Walgreens Boots Alliance, Inc. WBA
We take great care to ensure that the data presented and summarized in this overview for Walgreens Boots Alliance, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding WBA
View all-
Vanguard Group Inc Valley Forge, PA83.1MShares$996 Million0.02% of portfolio
-
Black Rock Inc. New York, NY70MShares$839 Million0.02% of portfolio
-
State Street Corp Boston, MA32.2MShares$386 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA23.1MShares$277 Million0.05% of portfolio
-
Fil LTD Hamilton, D020.6MShares$247 Million0.22% of portfolio
-
Geode Capital Management, LLC Boston, MA19.2MShares$230 Million0.02% of portfolio
-
Norges Bank Oslo, Q817.3MShares$207 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA15.3MShares$184 Million0.03% of portfolio
-
Morgan Stanley New York, NY12.2MShares$146 Million0.01% of portfolio
-
Candlestick Capital Management LP Greenwich, CT8.4MShares$101 Million1.97% of portfolio
Latest Institutional Activity in WBA
Top Purchases
Top Sells
About WBA
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Insider Transactions at WBA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 28
2025
|
Lanesha Minnix EVP, Global CLO & Corp. Sec. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
348,093
-100.0%
|
-
|
|
Aug 28
2025
|
Manmohan Mahajan EVP and Global CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
414,273
-100.0%
|
-
|
|
Aug 28
2025
|
Beth Amber L. Fabbri SVP Chief Corp Affairs Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
124,670
-100.0%
|
-
|
|
Aug 28
2025
|
Mary Langowksi EVP, President U.S. Healthcare |
SELL
Sale (or disposition) back to the issuer
|
Direct |
494,295
-100.0%
|
-
|
|
Aug 28
2025
|
Todd Heckman SVP, Global Controller and CAO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
93,037
-100.0%
|
-
|
|
Aug 28
2025
|
Timothy C Wentworth Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,332,014
-100.0%
|
-
|
|
Aug 28
2025
|
Tracey D Brown EVP, Pres., Walgreens Retail |
SELL
Sale (or disposition) back to the issuer
|
Direct |
348,051
-100.0%
|
-
|
|
Aug 28
2025
|
Elizabeth Burger EVP, Global Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
303,875
-100.0%
|
-
|
|
Aug 28
2025
|
Richard P. Gates SVP, Chief Pharmacy Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
145,444
-100.0%
|
-
|
|
Aug 28
2025
|
Stefano Pessina Executive Chairman of Board |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
145,621,079
-100.0%
|
$1,601,831,869
$11.45 P/Share
|
|
Aug 28
2025
|
Stefano Pessina Executive Chairman of Board |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,317,544
-100.0%
|
$14,492,984
$11.45 P/Share
|
|
Aug 28
2025
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,718,000
-100.0%
|
$18,898,000
$11.45 P/Share
|
|
Aug 28
2025
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Sale (or disposition) back to the issuer
|
Direct |
969,057
-100.0%
|
$10,659,627
$11.45 P/Share
|
|
Aug 13
2025
|
Bryan C Hanson Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,820
+26.09%
|
-
|
|
Aug 13
2025
|
Thomas E Polen Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,774
+29.4%
|
-
|
|
Aug 13
2025
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,820
+30.7%
|
-
|
|
Jun 01
2025
|
Lanesha Minnix EVP, Global CLO & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
19,135
-5.21%
|
$210,485
$11.23 P/Share
|
|
Jun 01
2025
|
Mary Langowksi EVP, President U.S. Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
40,304
-7.54%
|
$443,344
$11.23 P/Share
|
|
Jun 01
2025
|
Elizabeth Burger EVP, Global Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,495
-5.15%
|
$181,445
$11.23 P/Share
|
|
Apr 27
2025
|
Stefano Pessina Executive Chairman of Board |
BUY
Open market or private purchase
|
Indirect |
832,258
+0.57%
|
$9,154,838
$11.01 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 2.96M shares |
|---|---|
| Open market or private purchase | 832K shares |
| Sale (or disposition) back to the issuer | 153M shares |
|---|---|
| Payment of exercise price or tax liability | 273K shares |
| Open market or private sale | 832K shares |